ERBB2 and breast cancer: For the distinctive core signaling pathways of TNBC in the Figure 3 with red lines, receptor ERBB2, which was mutated in breast cancer, received microenvironment factor CCL28 to trigger TF STAT3 through signaling transduction proteins CDC42, ARRDC3, and MAPK9.